Predicted protein targets (top 1)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ROCK2 | O75116 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2940772 | 0.72 | FABP7 (0.36) | — | |
| SCHEMBL27649983 | 0.72 | RAB9A (0.40) | — | |
| Biphenyl SCHEMBL5598752 | 0.70 | POLB (0.31) | — | |
| SCHEMBL27826276 | 0.68 | FABP7 (0.33) | ROCK2 | |
| SCHEMBL6049898 | 0.68 | METAP2 (0.32) | — | |
| SCHEMBL6757083 | 0.68 | POLB (0.31) | — | |
| SCHEMBL4454309 | 0.67 | CYP3A4 (0.35) | — | |
| SCHEMBL16694069 | 0.65 | ROCK2 (0.48) | ROCK2 | |
| SCHEMBL29528000 | 0.65 | ROCK2 (0.48) | ROCK2 | |
| SCHEMBL29527663 | 0.65 | ROCK2 (0.42) | ROCK2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1437356-B1 | Copper complexes and the use thereof | LANXESS DEUTSCHLAND GMBH (DE) | 2006-03-29 | — | — | EP | claimed |
| US-20040198997-A1 | Copper complexes and their use | LANXESS DEUTSCHLAND GMBH (DE) | 2004-10-07 | — | — | US | claimed |
| US-7179946-B2 | Copper complexes and their use | LANXESS DEUTSCHLAND GMBH (DE) | 2007-02-20 | — | — | US | disclosed |
| US-6946577-B2 | Process for the production of aminodiphenylamines | BAYER AKTIENGESELLSCHAFT (DE) | 2005-09-20 | — | — | US | disclosed |
| US-20040198997-A1 | Copper complexes and their use | LANXESS DEUTSCHLAND GMBH (DE) | 2004-10-07 | — | — | US | disclosed |
| US-20040143139-A1 | Process for the production of aminodiphenylamines | LANXESS DEUTSCHLAND GMBH (DE) | 2004-07-22 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20040143139-A1 | Process for the production of aminodiphenylamines | NUDT1, ITPA, NAAA | ROCK2 4512/4885 |
| US-20040198997-A1 | Copper complexes and their use | SOD1, SOD3, ITPA | ROCK2 4494/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.